IDI1 Activators comprise a diverse group of compounds that interact with and enhance the activity of IDI1 (Isopentenyl-diphosphate Delta-isomerase 1), an enzyme pivotal in the isoprenoid biosynthesis pathway. This unique group includes both direct and indirect activators, covering a range of molecules from metabolic intermediates to enzyme that influence IDI1 activity by modulating the isoprenoid synthesis pathway. Compounds like geranylgeranyl pyrophosphate (GGPP) and farnesyl pyrophosphate (FPP), which are essential components in the synthesis of sterols and other isoprenoids, are believed to indirectly boost IDI1 activity. Their presence in the cellular environment may signal an increased demand for isoprenoid production, thereby enhancing the role of IDI1 in this process. Additionally, molecules like squalene, a key precursor in cholesterol synthesis, are thought to indirectly stimulate IDI1, highlighting the interconnected nature of metabolic pathways where the alteration in one segment can impact another.
Furthermore, the class includes statins like lovastatin and simvastatin, known for their role in inhibiting HMG-CoA reductase, a key enzyme in cholesterol biosynthesis. By reducing cholesterol synthesis, these compounds may create a compensatory mechanism that upregulates IDI1 to maintain isoprenoid production. This indirect activation illustrates the nuanced nature of metabolic regulation, where inhibition in one area can lead to activation in another. Other members of this class, such as mevalonate, IPP, DMAPP, and geraniol, are involved at various stages of the isoprenoid pathway, suggesting their role in modulating IDI1 activity. Zinc and magnesium ions, essential for numerous enzymatic activities, may also contribute to the optimal functioning of IDI1, either as cofactors or structural stabilizers. The "IDI1 Activators" class embodies a complex interplay of metabolic and regulatory compounds, each contributing to the fine-tuning of IDI1 activity, critical for the balanced synthesis of isoprenoids in cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geranylgeranylpyrophosphate triammonium salt | 6699-20-3 | sc-200849 | 200 µg | $122.00 | ||
GGPP may upregulate the isoprenoid pathway, indirectly increasing IDI1 activity. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $478.00 $1977.00 | ||
FPP, as a substrate in sterol synthesis, can enhance IDI1's role in isoprenoid production. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $49.00 $92.00 $215.00 | 1 | |
As a precursor in cholesterol synthesis, squalene may indirectly stimulate IDI1 activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
As a cofactor, zinc may be essential for IDI1's catalytic activity. | ||||||
Geraniol | 106-24-1 | sc-235242 sc-235242A | 25 g 100 g | $45.00 $119.00 | ||
As part of the terpenoid pathway, geraniol might influence IDI1 indirectly. | ||||||